The Deal: Deal Diary - Novo Nordisk Taps Davis Polk, Evercore on Emisphere

November 06, 2020

O’Melveny represented MHR’s interests in Novo Nordisk A/S’s agreement to buy Emisphere Technologies Inc. for US$1.35 billion. MHR and other Emisphere shareholders own a majority of the company’s shares and have agreed to vote their stock in favor of the deal, the publication reported.